Activation of Raf1 and the ERK pathway in response to l-ascorbic acid in acute myeloid leukemia cells

Cell Signal. 2005 Jan;17(1):111-9. doi: 10.1016/j.cellsig.2004.06.006.

Abstract

L-ascorbic acid (LAA) shows cytotoxicity and induces apoptosis of malignant cells in vitro, but the mechanisms by which such effects occur have not been elucidated. In the present study, we provide evidence that the ERK MAP kinase pathway is activated in response to LAA (< 1 mM) in acute myeloid leukemia cell lines. LAA treatment of cells induces a dose-dependent phosphorylation of extracellular signal-regulated kinases (ERK) and results in activation of its catalytic domain. Our data also demonstrate that the small G protein Raf1 and MAPK-activated protein kinase 2 are activated by LAA as an upstream and a downstream regulator of ERK, respectively. Although the ERK pathway has been known to activate cell proliferation, pharmacologic inhibition of ERK reduces LAA-dependent apoptosis and growth inhibitory response of acute myeloid leukemia cell lines, suggesting that this signaling cascade positively regulates induction of apoptotic response by LAA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects
  • Ascorbic Acid / pharmacology*
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • HL-60 Cells
  • Humans
  • Leukemia, Myeloid, Acute
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / physiology*
  • Phosphorylation
  • Proto-Oncogene Proteins c-raf / physiology*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*

Substances

  • Proto-Oncogene Proteins c-raf
  • Ascorbic Acid